Artal Participations S.a r.l.

Insider Reports History

Location
Luxembourg, Luxembourg
Signature
See Exhibit 99.1
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Artal Participations S.a r.l.:

Company Role Class Num Shares Value Price $ Report Date Ownership
CAVA GROUP, INC. Director Common Stock 9,507,990 $1,420,493,706 $149.40 05 Dec 2024 Direct
LEXICON PHARMACEUTICALS, INC. Director, 10%+ Owner Series B Convertible Preferred Stock 408,435 $26,548,255 $65.00 17 Feb 2026 Indirect

Insider Reports Filed by Artal Participations S.a r.l.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 17 Feb 2026 1 +$2,683,823 4 Director, 10%+ Owner 19 Feb 2026, 16:50
CAVA CAVA GROUP, INC. 05 Dec 2024 0 $0 3 Director 16 Dec 2024, 19:03
LXRX LEXICON PHARMACEUTICALS, INC. 05 Dec 2024 0 $0 3 Director, 10%+ Owner 16 Dec 2024, 19:00